Construction and identification of recombinant shuttle-plasmid pMVZ2A

Qingjie Xue(Jining Medical University), Wei Zhu(Ministry of Education of the People's Republic of China), Chen Ting(Tianjin Medical University)

Journal of Pathogen Biology

January 1, 2009

Cited by 0

Related Papers

Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway

|Annals of the Rheumatic Diseases|2011|412

Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across Diseases

|PLoS ONE|2012|196

A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients

|Annals of the Rheumatic Diseases|2013|168

A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth

|Oncogene|2011|135

Upstream regulators and downstream effectors of NF-κB in Alzheimer's disease

|Journal of the Neurological Sciences|2016|126